{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:09:26Z","timestamp":1792084166390,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04056-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:12:49Z","timestamp":1751339569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with prognosis in gastric cancer patients undergoing neoadjuvant chemotherapy: a meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Shuang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1631-3634","authenticated-orcid":false,"given":"Zhuoyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siman","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"3","key":"4056_CR1","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of gastric Cancer. Clin Gastroenterol Hepatol. 2020;18(3):534\u201342.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"4056_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.21147\/j.issn.1000-9604.2021.02.04","volume":"33","author":"J Chen","year":"2021","unstructured":"Chen J, Bu Z, Ji J. Surgical treatment of gastric cancer: current status and future directions. Chin J Cancer Res. 2021;33(2):159\u201367.","journal-title":"Chin J Cancer Res"},{"issue":"Suppl 2","key":"4056_CR3","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1517\/14728222.2011.652616","volume":"16","author":"F De Vita","year":"2012","unstructured":"De Vita F, Giuliani F, Silvestris N, Rossetti S, Pizzolorusso A, Santabarbara G, Galizia G, Colucci G, Ciardiello F, Orditura M. Current status of targeted therapies in advanced gastric cancer. Expert Opin Ther Targets. 2012;16(Suppl 2):S29\u201334.","journal-title":"Expert Opin Ther Targets"},{"key":"4056_CR4","doi-asserted-by":"crossref","unstructured":"Gan X, Li S, Wang Y, Du H, Hu Y, Xing X, Cheng X, Yan Y, Li Z. Aspartate beta-Hydroxylase serves as a prognostic biomarker for neoadjuvant chemotherapy in gastric Cancer. Int J Mol Sci 2023;24(6).","DOI":"10.3390\/ijms24065482"},{"key":"4056_CR5","doi-asserted-by":"crossref","unstructured":"Sato Y, Okamoto K, Kawaguchi T, Nakamura F, Miyamoto H, Takayama T. Treatment response predictors of neoadjuvant therapy for locally advanced gastric cancer: current status and future perspectives. Biomedicines 2022;10(7).","DOI":"10.3390\/biomedicines10071614"},{"key":"4056_CR6","doi-asserted-by":"crossref","unstructured":"Arai H, Nakajima TE. Recent developments of systemic chemotherapy for gastric cancer. Cancers (Basel) 2020;12(5).","DOI":"10.3390\/cancers12051100"},{"issue":"2","key":"4056_CR7","first-page":"1238","volume":"18","author":"W Feng","year":"2018","unstructured":"Feng W, Zhu X. Efficacy prediction of targeted therapy for gastric cancer: the current status (Review). Mol Med Rep. 2018;18(2):1238\u201346.","journal-title":"Mol Med Rep"},{"key":"4056_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ijsu.2018.06.037","volume":"56","author":"LX Zhang","year":"2018","unstructured":"Zhang LX, Wei ZJ, Xu AM, Zang JH. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study. Int J Surg. 2018;56:320\u20137.","journal-title":"Int J Surg"},{"key":"4056_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12967-015-0409-0","volume":"13","author":"Q Deng","year":"2015","unstructured":"Deng Q, He B, Liu X, Yue J, Ying H, Pan Y, Sun H, Chen J, Wang F, Gao T, et al. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med. 2015;13:66.","journal-title":"J Transl Med"},{"key":"4056_CR10","doi-asserted-by":"publisher","first-page":"1408700","DOI":"10.3389\/fimmu.2024.1408700","volume":"15","author":"S Tan","year":"2024","unstructured":"Tan S, Zheng Q, Zhang W, Zhou M, Xia C, Feng W. Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Front Immunol. 2024;15:1408700.","journal-title":"Front Immunol"},{"key":"4056_CR11","doi-asserted-by":"publisher","first-page":"156389","DOI":"10.1016\/j.cyto.2023.156389","volume":"172","author":"M Skorzewska","year":"2023","unstructured":"Skorzewska M, Pikula A, Geca K, Mlak R, Rawicz-Pruszynski K, Sedlak K, Pasnik I, Polkowski WP. Systemic inflammatory response markers for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer. Cytokine. 2023;172:156389.","journal-title":"Cytokine"},{"key":"4056_CR12","doi-asserted-by":"publisher","first-page":"1029960","DOI":"10.3389\/fonc.2022.1029960","volume":"12","author":"M Wan","year":"2022","unstructured":"Wan M, Ding Y, Mao C, Ma X, Li N, Xiao C, Qian J, Jiang H, Zheng Y, Wu L, et al. Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatment. Front Oncol. 2022;12:1029960.","journal-title":"Front Oncol"},{"issue":"7","key":"4056_CR13","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"15","key":"4056_CR14","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"key":"4056_CR15","doi-asserted-by":"publisher","first-page":"153303381982948","DOI":"10.1177\/1533033819829485","volume":"18","author":"L Chen","year":"2019","unstructured":"Chen L, Hao Y, Cong X, Zou M, Li S, Zhu L, Song H, Xue Y. Peripheral venous blood Platelet-to-Lymphocyte ratio (PLR) for predicting the survival of patients with gastric Cancer treated with SOX or XELOX regimen neoadjuvant chemotherapy. Technol Cancer Res Treat. 2019;18:1533033819829485.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"4056_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00262-021-02960-1","volume":"71","author":"IV Zurlo","year":"2022","unstructured":"Zurlo IV, Schino M, Strippoli A, Calegari MA, Cocomazzi A, Cassano A, Pozzo C, Di Salvatore M, Ricci R, Barone C, et al. Predictive value of NLR, TILs (CD4+\/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer. Cancer Immunol Immunother. 2022;71(1):45\u201355.","journal-title":"Cancer Immunol Immunother"},{"key":"4056_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1477-7819-11-112","volume":"11","author":"H Jin","year":"2013","unstructured":"Jin H, Zhang G, Liu X, Liu X, Chen C, Yu H, Huang X, Zhang Q, Yu J. Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy. World J Surg Oncol. 2013;11:112.","journal-title":"World J Surg Oncol"},{"issue":"3","key":"4056_CR18","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s10120-019-01027-6","volume":"23","author":"Z Li","year":"2020","unstructured":"Li Z, Li S, Ying X, Zhang L, Shan F, Jia Y, Ji J. The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy. Gastric Cancer. 2020;23(3):540\u20139.","journal-title":"Gastric Cancer"},{"issue":"1","key":"4056_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12885-023-10712-w","volume":"23","author":"J Yang","year":"2023","unstructured":"Yang J, Li J, Deng Q, Chen Z, He K, Chen Y, Fu Z. Effect of neoadjuvant chemotherapy combined with arterial chemoembolization on short-term clinical outcome of locally advanced gastric cancer. BMC Cancer. 2023;23(1):246.","journal-title":"BMC Cancer"},{"key":"4056_CR20","doi-asserted-by":"crossref","unstructured":"Pikula A, Skorzewska M, Pelc Z, Mlak R, Geca K, Sedlak K, Cisel B, Kwietniewska M, Rawicz-Pruszynski K, Polkowski WP. Prognostic value of systemic inflammatory response markers in patients undergoing neoadjuvant chemotherapy and gastrectomy for advanced gastric cancer in the Eastern European population. Cancers (Basel) 2022;14(8).","DOI":"10.3390\/cancers14081997"},{"key":"4056_CR21","doi-asserted-by":"crossref","unstructured":"Pelc Z, Sedlak K, Mlak R, Lesniewska M, Mielniczek K, Rola P, Januszewski J, Zhaldak O, Rekowska A, Geca K et al. Prognostic value of inflammatory burden index in advanced gastric cancer patients undergoing multimodal treatment. Cancers (Basel) 2024;16(4).","DOI":"10.3390\/cancers16040828"},{"issue":"15suppl","key":"4056_CR22","doi-asserted-by":"publisher","first-page":"e16030","DOI":"10.1200\/JCO.2021.39.15_suppl.e16030","volume":"39","author":"Y Liu","year":"2021","unstructured":"Liu Y, Meng Q, Zhou Z, Jing L. Changes in neutrophil \/lymphocyte ratio and platelet count after chemotherapy correlate with cheomtherapy response and predicition of prognosis in patients with advanced gastric cancer. J Clin Oncol. 2021;39(15suppl):e16030\u201316030.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4056_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.21873\/invivo.13089","volume":"37","author":"N Urakawa","year":"2023","unstructured":"Urakawa N, Kanaji S, Kato T, Sawada R, Harada H, Goto H, Hasegawa H, Yamashita K, Matsuda T, Oshikiri T, Kakeji Y. Neutrophil-lymphocyte ratio and histological response correlate with prognosis of gastric Cancer undergoing neoadjuvant chemotherapy. Vivo. 2023;37(1):378\u201384.","journal-title":"Vivo"},{"issue":"5","key":"4056_CR24","doi-asserted-by":"publisher","first-page":"e22364","DOI":"10.1002\/jcla.22364","volume":"32","author":"W Gong","year":"2018","unstructured":"Gong W, Zhao L, Dong Z, Dou Y, Liu Y, Ma C, Qu X. After neoadjuvant chemotherapy platelet\/lymphocyte ratios negatively correlate with prognosis in gastric cancer patients. J Clin Lab Anal. 2018;32(5):e22364.","journal-title":"J Clin Lab Anal"},{"key":"4056_CR25","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.2147\/OTT.S134716","volume":"10","author":"L Chen","year":"2017","unstructured":"Chen L, Zuo Y, Zhu L, Zhang Y, Li S, Ma F, Han Y, Song H, Xue Y. Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy. Onco Targets Ther. 2017;10:2569\u201380.","journal-title":"Onco Targets Ther"},{"key":"4056_CR26","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.2147\/OTT.S176768","volume":"11","author":"C Tang","year":"2018","unstructured":"Tang C, Cheng X, Yu S, Wang Y, Hou J, Li Q, Shen Z, Liu T, Cui Y. Platelet-to-lymphocyte ratio and lymphocyte-to-white blood cell ratio predict the efficacy of neoadjuvant chemotherapy and the prognosis of locally advanced gastric cancer patients treated with the oxaliplatin and capecitabine regimen. Onco Targets Ther. 2018;11:7061\u201375.","journal-title":"Onco Targets Ther"},{"key":"4056_CR27","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2147\/RMHP.S413052","volume":"16","author":"G Wang","year":"2023","unstructured":"Wang G, Tan Y, Jiang Y, Liu J, Su Y, Sun Z, Liu B. Prognostic model of D2 radical gastrectomy combined with neoadjuvant chemotherapy for gastric Cancer. Risk Manag Healthc Policy. 2023;16:1259\u201371.","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"4056_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11845-019-02153-x","volume":"189","author":"A Yilmaz","year":"2020","unstructured":"Yilmaz A, Mirili C, Tekin SB, Bilici M. The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study. Ir J Med Sci. 2020;189(1):91\u2013102.","journal-title":"Ir J Med Sci"},{"issue":"12","key":"4056_CR29","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12032-014-0311-2","volume":"31","author":"LM el Aziz","year":"2014","unstructured":"el Aziz LM. Blood neutrophil-lymphocyte ratio predicts survival in locally advanced cancer stomach treated with neoadjuvant chemotherapy FOLFOX 4. Med Oncol. 2014;31(12):311.","journal-title":"Med Oncol"},{"issue":"Suppl 1null","key":"4056_CR30","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1007\/s10875-012-9847-0","volume":"33","author":"J Candido","year":"2013","unstructured":"Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013;33(Suppl 1null):S79\u201384.","journal-title":"J Clin Immunol"},{"key":"4056_CR31","doi-asserted-by":"crossref","unstructured":"Sylman JL, Mitrugno A, Atallah M, Tormoen GW, Shatzel JJ, Tassi Yunga S, Wagner TH, Leppert JT, Mallick P, McCarty OJT. The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis. Frontiers in oncology 2018;8(null):78.","DOI":"10.3389\/fonc.2018.00078"},{"issue":"null","key":"4056_CR32","doi-asserted-by":"publisher","first-page":"1408700","DOI":"10.3389\/fimmu.2024.1408700","volume":"15","author":"S Tan","year":"2024","unstructured":"Tan S, Zheng Q, Zhang W, Zhou M, Xia C, Feng W. Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Front Immunol. 2024;15(null):1408700.","journal-title":"Front Immunol"},{"issue":"17","key":"4056_CR33","doi-asserted-by":"publisher","first-page":"5983","DOI":"10.1002\/cam4.4143","volume":"10","author":"M Naszai","year":"2021","unstructured":"Naszai M, Kurjan A, Maughan TS. The prognostic utility of pre-treatment neutrophil-to-lymphocyte-ratio (NLR) in colorectal cancer: A systematic review and meta-analysis. Cancer Med. 2021;10(17):5983\u201397.","journal-title":"Cancer Med"},{"issue":"4","key":"4056_CR34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/annonc\/mdw012","volume":"27","author":"T Grenader","year":"2016","unstructured":"Grenader T, Waddell T, Peckitt C, Oates J, Starling N, Cunningham D, Bridgewater J. Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial. Ann Oncol. 2016;27(4):687\u201392.","journal-title":"Ann Oncol"},{"key":"4056_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12957-015-0530-9","volume":"13","author":"J Chen","year":"2015","unstructured":"Chen J, Hong D, Zhai Y, Shen P. Meta-analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer. World J Surg Oncol. 2015;13:122.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4056_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00423-023-02786-8","volume":"408","author":"G Portale","year":"2023","unstructured":"Portale G, Bartolotta P, Azzolina D, Gregori D, Fiscon V. Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis. Langenbecks Arch Surg. 2023;408(1):85.","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"4056_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/DCR.0000000000002291","volume":"65","author":"HKS Hamid","year":"2022","unstructured":"Hamid HKS, Emile SH, Davis GN. Prognostic significance of Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte ratio in rectal cancer: A systematic review, Meta-analysis, and Meta-regression. Dis Colon Rectum. 2022;65(2):178\u201387.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"4056_CR38","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1186\/s12885-019-5892-x","volume":"19","author":"S Dudani","year":"2019","unstructured":"Dudani S, Marginean H, Tang PA, Monzon JG, Raissouni S, Asmis TR, Goodwin RA, Gotfrit J, Cheung WY, Vickers MM. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation. BMC Cancer. 2019;19(1):664.","journal-title":"BMC Cancer"},{"issue":"3","key":"4056_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3393\/ac.2021.00633.0090","volume":"38","author":"SH An","year":"2022","unstructured":"An SH, Kim IY. Can pretreatment platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict long-term oncologic outcomes after preoperative chemoradiation followed by surgery for locally advanced rectal cancer? Ann Coloproctol. 2022;38(3):253\u201361.","journal-title":"Ann Coloproctol"},{"key":"4056_CR40","doi-asserted-by":"crossref","unstructured":"Gou M, Qu T, Wang Z, Yan H, Si Y, Zhang Y, Dai G. Neutrophil-to-lymphocyte ratio (NLR) predicts PD-1 inhibitor survival in patients with metastatic gastric cancer. Journal of Immunology Research 2021, 2021(null):2549295.","DOI":"10.1155\/2021\/2549295"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04056-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04056-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04056-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:12:57Z","timestamp":1751339577000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04056-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4056"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04056-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was conducted in strict accordance with the relevant provisions of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"445"}}